What Medica does

Medica S.p.A. is an Italian medical device company founded in 1985 in the Mirandola biomedical district (Medolla, province of Modena), specializing in hollow fiber (capillary) membrane technology for blood purification and water treatment. Its three business units — Medical Sector, Water Purification, and Turnkey Solutions — produce dialyzers, CRRT sets, apheresis filters, the Carpe Diem neonatal dialysis system (now distributed in the US via Medtronic), the AD1 wearable ultrafiltration device, urology and gastroenterology diagnostic equipment, and graphene-enhanced water filters (Graphil, Graphisulfone®) developed with CNR. The Turnkey Solutions unit provides OEM development and manufacturing of electromedical devices, single-use disposables, custom hollow fiber membranes, and full automation lines via the wholly-owned Tecnoideal subsidiary (acquired 1990).

The company operates a vertically integrated model spanning in-house membrane formulation (polysulfone, MediSulfone®, graphene-enhanced polymers), proprietary extrusion line design, finished-device assembly, testing, and packaging. It serves hospitals, dialysis centers, ICUs, water utilities, and other medical device manufacturers across more than 35 countries, primarily through direct enterprise sales, three international subsidiaries (UK 2022, USA 2022, China 2024), distribution partners, and Italian public procurement (Consip). Revenue is generated almost entirely from hardware sales across the four streams — Medical Devices and Consumables, Water Purification, OEM/Turnkey Solutions, and Industrial Automation — with quote-based, non-public pricing.

Following its November 2021 listing on Euronext Growth Milan, Medica was acquired in Q3 2024 by Donaldson Company Inc. (US-listed filtration multinational), which took a 49% stake via tender offer and disclosed 2024 revenue of approximately $135.9 million. Medica was subsequently delisted and integrated into Donaldson's Life Sciences segment, with Donaldson holding options to acquire the remaining 51%. The company employs approximately 650 people globally and is led by CEO Marco Fecondini (since 2023), with founder Luciano Fecondini as Chairman.

Name

Medica

Legal name

Medica S.p.A.

Website

https://medica-spa.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Medica S.p.A. is an Italian medical device company that designs and manufactures hollow fiber membrane-based products for blood purification, water treatment, and OEM medical device manufacturing. It serves hospitals, dialysis centers, water utilities, and medical device companies globally across more than 35 countries.

Ownership category

akta.pro rank

Product category

Medical Devices (Blood Purification / Hollow Fiber Membrane Technology)

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medical & Pharmaceutical Thermoformed Packaging (IMANAHAB)

akta.pro secondary industries

Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Rigid Pharmaceutical & Healthcare Plastic Packaging (Pill Bottles, Vials, Med-Grade Jars) (IMALAAAE)

Keywords

• Blood purification devices
• Hollow fiber membranes
• Dialysis equipment
• Medical device manufacturing
• Water filtration membranes

Headquarters

HQ city

Medolla

HQ country

Italy

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Medical Devices and Consumables: Sale of blood purification devices (dialyzers, CRRT sets, apheresis filters, single-use tubing sets, catheters), electro-medical equipment, and urology/gastroenterology diagnostic devices to hospitals and healthcare providers globally.
2. Water Purification Membranes and Filters: Sale of hollow fiber membranes and filters for water purification in medical and commercial applications, including commercial water filters and Graphil/Graphisulfone consumer-point-of-use filters.
3. OEM / Turnkey Solutions: Development and manufacturing services for other medical device companies, providing electro-medical devices, single-use disposables, membranes/filters, and custom assembly lines on a project or supply basis. Includes co-design and mass production services.
4. Industrial Automation Systems: Through Tecnoideal srl, design and supply of custom automation systems and assembly lines for medical device and membrane manufacturing.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Medica S.p.A. designs, develops, and manufactures medical devices and water purification products based on proprietary hollow fiber capillary membrane technology. Operating through three business units — Medical Sector (dialysis, CRRT, therapeutic apheresis, cardiology, oncology surgery, urology, and gastroenterology devices), Water Purification (commercial and medical water filters including Graphil and Graphisulfone® graphene-enhanced filters), and Turnkey Solutions (OEM manufacturing of disposable medical devices, electro-medical equipment, hollow fiber membranes/filters, and custom assembly lines via its Tecnoideal subsidiary). The company sells directly to hospitals and healthcare facilities, via public procurement, and through OEM agreements with other medical device manufacturers.

Product overview

Medica S.p.A. is a medical device and water purification technology company operating since 1985 from the biomedical district of Mirandola, Italy. The company operates three Business Units: SETTORE MEDICALE (Medical Sector), PURIFICAZIONE ACQUA (Water Purification), and TURNKEY SOLUTIONS. The Medical Sector represents its core business with nearly 40 years of hollow fiber membrane expertise serving dialysis, CRRT, therapeutic apheresis, cardiology, oncology surgery, and urology/gastroenterology. The Water Purification division applies blood filtration know-how to commercial and medical water filters, including branded products like Graphil and Graphisulfone® developed with CNR. The Turnkey Solutions unit provides OEM manufacturing of disposable medical devices, electromedical equipment, hollow fiber membranes and filters, and custom assembly lines through its subsidiary Tecnoideal srl. Notable products include Carpe Diem (neonatal dialysis, acquired by Medtronic), AD1 (wearable ultrafiltration), MediSulfone® hollow fiber, and the PuriFi OEM electromedical device for CytoSorbents.

Differentiator

Problem solved

Functional benefit

Brands

• Graphil: Water purification filters enriched with graphene for drinking water treatment, targeting emerging contaminants including PFAS
• Graphisulfone®
• Carpe Diem
• AD1
• MediSulfone®

Products and services

• SETTORE MEDICALE (Medical Sector — Blood Purification Devices) Hollow fiber membrane-based blood purification medical devices for dialysis, CRRT, therapeutic apheresis, cardiology, oncological surgery, organ transplantation, urology, gastroenterology, and veterinary applications. Sold to hospitals, dialysis centers, and ICUs globally.
• PURIFICAZIONE ACQUA (Water Purification) Hollow fiber membrane products for water purification in commercial and medical settings, leveraging expertise from blood filtration technology. Includes commercial water filters and medical water filters.
• TURNKEY SOLUTIONS (OEM Manufacturing Services) OEM manufacturing services including disposable medical devices, electro-medical equipment, custom hollow fiber membranes and filters, and custom assembly lines for the biomedical sector. Sold to other medical device manufacturers.
• Elettromedicali - OEM (Electromedical OEM Equipment) Design and manufacture of electromedical equipment including dialysis, CRRT, apheresis, cardiology, oncology surgery, and urology/gastroenterology diagnostic systems on an OEM basis for other medical device companies.
• Dispositivi Monouso - OEM (Disposable Medical Devices OEM) Design and manufacture of single-use medical device circuits including tubing sets, blood bags, and catheters using biocompatible polymers, supporting electromedical equipment for patient treatment management. OEM supply to other medical device companies.
• Membrane & Filtri - OEM (Hollow Fiber Membranes & Filters OEM) Custom hollow fiber membrane and filter development using phase inversion extrusion technology, including prototyping, proof-of-principle validation, certification, and mass production. OEM supply to other medical device manufacturers.
• Linee Assemblaggio Personalizzate (Custom Assembly Lines) Custom automation equipment and assembly line development for single-use medical device production through the subsidiary Tecnoideal srl, covering extrusion, assembly, testing, and packaging.
• Carpe Diem (Neonatal Blood Purification System) Miniaturized blood purification machine designed specifically for neonates with low body weight suffering from acute kidney injury and cardio-renal problems. Described as the only device of its kind in the world for neonatal renal support.
• AD1 (Wearable Continuous Ultrafiltration Device) Wearable device for continuous and isolated ultrafiltration designed for patients with cardio-renal insufficiency. The smallest and lightest in its category, battery-powered, with ready-to-use kit and safety sensors. Co-developed with IRRIV.
• Graphil (Graphene-Enhanced Water Filters) Point-of-use water filters enriched with graphene oxide for tap water purification, targeting emerging contaminants (PFAS, pharmaceuticals, heavy metals) and reducing plastic bottle consumption.
• Graphisulfone® (Graphene-Polysulfone Membrane Material) Advanced filtering material integrating graphene within polysulfone hollow fiber membranes for water purification. Effective against PFAS, pharmaceuticals, and heavy metals including lead, with higher efficiency than traditional granular activated carbon.
• Filtri Commerciali (Commercial Water Filters) Hollow fiber membrane filters for commercial water purification applications, providing protection based on pore size and adsorbent capacity of the membranes.
• Filtri Medicali (Medical Water Filters) Hollow fiber membrane filters for medical water purification applications, leveraging the same technology used in blood purification.
• PuriFi (OEM Hemoadsorption Electromedical Device) OEM electro-medical device co-developed with CytoSorbents specifically for hemoadsorption applications, enabling rapid setup for Cytosorb adsorber therapy in critical care.

Quantifiable outcome

• Carpe Diem is the only neonatal blood purification device designed for low body weight neonates, now available globally via Medtronic.
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• CytoSorbents CorporationcoreOEM/ Whitelabel/ Licensing PartnerMedica designed and manufactures the PuriFi OEM electromedical device specifically for CytoSorbents' hemoadsorption therapy using Cytosorb adsorbers. PuriFi enables rapid setup and easy use of CytoSorbents' toxin-removal technology in critical care settings.
• Consiglio Nazionale delle Ricerche (CNR)coreStrategic or Co-development PartnerLong-standing R&D collaboration with CNR-ISOF (Bologna) for membrane technology development. Joint outcomes include Graphil and Graphisulfone® (registered trademark shared between Medica and CNR). CNR collaboration also includes physical, biological, and performance characterization of filters and membranes. Medica is a co-partner in Graphene Flagship (EU initiative).
• IRRIV — Istituto di Ricerca Renale di VicenzacoreStrategic or Co-development PartnerCollaboration with Prof. Claudio Ronco's IRRIV resulted in Carpe Diem (neonatal dialysis system) and AD1 (wearable ultrafiltration device). IRRIV provided clinical research expertise and the clinical setting for development.
• MISTER Smart InnovationminorStrategic or Co-development PartnerCo-partner with CNR of Bologna and multiple industrial entities. MISTER Smart Innovation is a shared research society developing cutting-edge technologies, with Medica as a founding member.
• Graphene Flagship (EU)coreStrategic or Co-development PartnerMedica S.p.A. is a partner of the Graphene Flagship, a major EU research initiative. The company coordinates the Graphil project through this network of academic and industrial partners (CNR, Chalmers University, University of Manchester).
• Life Remembrance (EU co-funded project)coreStrategic or Co-development PartnerMedica is the coordinator of the Life Remembrance project, co-funded by the European Union, which develops circular economy solutions by repurposing hollow fiber membrane production waste into adsorptive water filters. The Water Living Lab at HERA Group's Pontelagoscuro plant is a key outcome.
• MedtroniccoreChannel Partner/ Reseller/ DistributorMedtronic acquired and distributes the Carpe Diem neonatal renal support technology developed by Medica with IRRIV, making it available to US patients.
• Gruppo HERAminorStrategic or Co-development PartnerHERA Group hosted the Water Living Lab pilot installation at its Pontelagoscuro drinking water treatment plant, validating Medica/CNR Life Remembrance filter technology in a real-world water treatment setting.
• Spindial S.p.A.coreOthersMedica increased its stake in Spindial S.p.A. from 51% to 79% in June 2025 via a capital increase, strengthening its hemodialysis market position ahead of the Consip V national procurement tender.

Scale indicators10 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Fresenius Medical Care: Global leader in dialysis products and services, including dialyzers and CRRT equipment that compete directly with Medica's blood purification portfolio. Largest player in the renal care market with vertically integrated clinic networks, and the primary scale competitor Medica faces in hospital and dialysis-center channels.
• Baxter International: Major manufacturer of dialysis products (Vantive renal care business) and broader medical devices including blood purification therapies. Directly competes with Medica in dialyzers, CRRT, and apheresis filters across global hospital channels.
• B. Braun: German medical device multinational with a substantial dialysis business (B. Braun Avitum) producing dialyzers, CRRT systems, and apheresis products. Comparable mid-to-large-scale European competitor with similar OEM manufacturing capabilities and global hospital channel reach.
• Asahi Kasei Medical: Manufacturer of hollow fiber membranes (PLANOVA virus removal filters and dialysis membranes) for medical applications. Direct technology peer in phase-inversion hollow fiber membrane manufacturing, competing in adjacent membrane categories used for blood purification and bioprocessing.
• Toray Medical: Medical division of Toray Industries, producing polysulfone hollow fiber membranes for hemodialysis (TORAYLIGHT). One of the closest direct competitors to Medica's MediSulfone® and CRRT/dialyzer product lines, with comparable membrane chemistry expertise and global distribution.
• Nipro Corporation: Japanese medical device manufacturer with a significant dialysis business producing dialyzers, blood tubing sets, and dialysis machines. Comparable portfolio breadth in single-use disposables and blood purification devices, with strong presence in Asia-Pacific markets where Medica is expanding.

Emerging players

• Outset Medical: US-based medical device company with the Tablo home and acute dialysis system, addressing modernization of in-clinic and home dialysis. Competes in adjacent dialysis hardware innovation space with differentiated form-factor and digital features, representing a new entrant in Medica's dialysis end market.
• CytoSorbents Corporation: US-based critical care company producing CytoSorb hemoadsorption cartridges for cytokine and toxin removal in ICU settings — partnered with Medica for the PuriFi OEM device. Comparable focus on blood purification adjacencies, though with a different modality (adsorption vs. membrane filtration) and a smaller commercial footprint.

Broad incumbents

• Donaldson Company Inc. US-listed global filtration multinational and Medica's majority owner (49% with option for 51%). Operates broadly across industrial filtration, life sciences, and clean air/liquid solutions, providing scale, channel, and capital that frames Medica's strategic context and partially overlaps in industrial membrane applications.
• Pall Corporation: Filtration and purification business within Danaher, producing membranes and filters for medical, biopharmaceutical, and industrial water applications. Broad incumbent in adjacent filtration categories where Medica's water purification business competes for institutional and bioprocessing customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medica